The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy

被引：272

作者：

Wang, Ji ^{[1
,2
,3
]}

Xie, Shuduo ^{[1
,2
,3
]}

Yang, Jingjing ^{[1
,2
,3
]}

Xiong, Hanchu ^{[1
,2
,3
]}

Jia, Yunlu ^{[1
,2
,3
]}

Zhou, Yulu ^{[1
,2
,3
]}

Chen, Yongxia ^{[1
,2
,3
]}

Ying, Xiaogang ^{[1
,2
,3
]}

Chen, Cong ^{[1
,2
,3
]}

Ye, Chenyang ^{[4
]}

Wang, Linbo ^{[1
,2
,3
]}

Zhou, Jichun ^{[1
,2
,3
]}

机构：

[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Surg Oncol, 3 Eastern Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China

[2] Biomed Res Ctr, Hangzhou 310016, Zhejiang, Peoples R China

[3] Key Lab Biotherapy Zhejiang Prov, Hangzhou 310016, Zhejiang, Peoples R China

[4] Zhejiang Univ, Affiliated Hosp 2, Key Lab Canc Prevent & Intervent, Sch Med,Natl Minist Educ,Canc Inst, Hangzhou 310009, Zhejiang, Peoples R China

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2019年 / 12卷 / 1期

基金：

中国国家自然科学基金;

关键词：

LncRNA H19; Autophagy; Methylation; Beclin1; Breast cancer; Tamoxifen resistance; GLOBAL GENE REPRESSION; ESTROGEN-RECEPTOR; ENDOCRINE THERAPY; CELL-PROLIFERATION; INHIBITS AUTOPHAGY; GROWTH; DIFFERENTIATION; MACROAUTOPHAGY; METHYLATION; EXPRESSION;

D O I：

10.1186/s13045-019-0747-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

BackgroundTamoxifen resistance remains a clinical challenge for hormone receptor-positive breast cancer. Recently, dysregulations in autophagy have been suggested as a potential mechanism for tamoxifen resistance. Although the long noncoding RNA H19 is involved in various stages of tumorigenesis, its role in tamoxifen resistance remains unknown. Here, we assessed the role of H19 in the development of tamoxifen-resistant breast cancer.MethodsQuantitative real-time PCR analyzed expression of H19 in tamoxifen-resistant breast cancer tissues. Knockdown of H19 was used to assess the sensitivity to tamoxifen in vitro and in vivo. Both knockdown and overexpression of H19 were used to analyze the status of autophagy. Real-time quantitative methylation-specific polymerase chain reaction, chromatin immunoprecipitation, immunofluorescence, and Western blot were used to explore the tamoxifen resistance mechanism of H19.ResultsIn this study, we observed that the expression of H19 was substantially upregulated in tamoxifen-resistant breast cancer cell line and tumor tissues, and knockdown of H19 enhanced the sensitivity to tamoxifen both in vitro and in vivo. Furthermore, knockdown of H19 significantly inhibited autophagy in MCF7 tamoxifen-resistant (MCF7/TAMR) cells. Conversely, overexpression of H19 promoted autophagy. Interestingly, overexpression of H19 in MCF7 tamoxifen-sensitive cells could recapitulate tamoxifen resistance. Moreover, an increase in methylation in the promoter region of Beclin1 was observed in MCF7/TAMR-shH19 cells. In the double knockdown groups, both shH19+shSAHH and shH19+shDNMT3B rescued the Beclin1 promoter region methylation levels and reactivated autophagy functions. A chromatin immunoprecipitation assay further validated that DNMT3B binds to the Beclin1 promoter region and the knockdown of H19 increases this binding.ConclusionsOur findings demonstrate that H19 induces autophagy activation via the H19/SAHH/DNMT3B axis, which could contribute to tamoxifen resistance in breast cancer.

引用

页数：14

共 62 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0

[2]

Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance [J].